hearing loss

Frequency bags $62M to advance Astellas-partnered hearing loss drug
Fierce Biotech
Tue, 07/23/19 - 10:10 am
Frequency Therapeutics
hearing loss
Astellas
FX-322
On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas
BioCentury
Wed, 07/17/19 - 10:46 am
Frequency Therapeutics
hearing loss
FX-322
Astellas
Frequency Nabs $42M for Hearing Loss Drugs, Clinical Data On The Way
Xconomy
Mon, 01/7/19 - 11:18 am
Frequency Therapeutics
hearing loss
Strike two: Auris shares crushed again as its second PhIII program fails to deliver
Endpoints
Tue, 11/28/17 - 10:57 am
Auris Medical
AM-111
hearing loss
tinnitus
Google’s data-crunching mavens at GV buy in to Decibel’s R&D program for hearing loss, tinnitus
Endpoints
Thu, 07/6/17 - 09:45 am
Google Ventures
Decibel Therapeutics
hearing loss
tinnitus
R&D
Hearing loss biotech Frequency Therapeutics dials up $32M round
Bizjournals.com
Tue, 04/11/17 - 10:13 am
hearing loss
Frequency Therapeutics
FDA lifts a hold on a Novartis hearing loss drug, and tiny GenVec gets a lift
Endpoints
Mon, 07/25/16 - 06:23 pm
FDA
Novartis
hearing loss
GenVec
CGF166
Biotech veteran taking the reins of hearing loss startup
Stat
Wed, 07/13/16 - 10:41 am
hearing loss
biotech
Decibel Therapeutics
Swiss hearing loss firm Auris Medical to raise up to $95 million in US IPO
Reuters
Mon, 07/21/14 - 10:39 am
IPOs
Auris Medical
hearing loss
Roche teams up with VC in hearing loss project
Pharma Times, UK
Thu, 10/11/12 - 09:32 am
Roche
hearing loss
venture capital
GenVec Extends Research Collaboration with Global Pharmaceutical Company
Bradenton Herald, FL
Sat, 01/28/12 - 12:51 pm
GenVec
Novartis
hearing loss
Sanofi hunts for drugs against hearing loss
Reuters
Thu, 06/16/11 - 11:33 am
Sanofi
hearing loss
Audion
Novartis, GenVec to develop hearing-loss treatment in $214M deal
Bizjournals.com
Tue, 01/19/10 - 09:18 pm
hearing loss
Novartis
GenVec
partnerships

Pages